AVANIR Pharmaceuticals, Inc. is a biopharmaceutical company focused on acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders.
abreva® (docosanol 10% cream)
Zenvia™ for PBA MIF Inhibitor Zenvia™ for Diabetic Peripheral Neuropathic Pain
Zenvia™ for Pseudobulbar Affect (PBA)
Lazard Capital Markets 6th Annual Healthcare ConferenceDate: Nov 18, 2009Begins: 3:15 p.m. ET
BIOCOM Investor ConferenceDate: Oct 26, 2009Begins: 2:30 p.m. ET
Nov 17, 2009AVANIR Pharmaceuticals Invites Investors to Fourth Quarter and Fiscal Year End Conference Call
Nov 11, 2009AVANIR to Present at the Lazard Healthcare Conference
Nov 10, 2009Avanir Pharmaceuticals Announces Zenvia Safety and Efficacy Data from Star Trial Open Label Extension
abreva® (docosanol 10% cream)
